Tag: Trastuzumab deruxtecan

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Trastuzumab deruxtecan

ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product

Added to Collection on: 2024-11-08 17:09:46

Tags for this article:

Immunology
Orphan drugs
Antibody-drug conjugates
Antineoplastic drugs
Daiichi Sankyo
Trastuzumab deruxtecan
Antibody-drug conjugate
HER2
Trastuzumab
AstraZeneca
Breast cancer

Click the tags to see associated articles and topics

View Article Details
New and Evolving: Pretreatment Risk Factors for Pneumonitis and Trastuzumab-Deruxtecan

Added to Collection on: 2025-02-20 19:41:20

Tags for this article:

Antibody-drug conjugates
Immunology
Breast cancer
Antineoplastic drugs
HER2
Trastuzumab deruxtecan
Trastuzumab emtansine
Trastuzumab
Antibody-drug conjugate
Deruxtecan
Pneumonitis
Genentech

Click the tags to see associated articles and topics

View Article Details
Antibody-Drug Conjugates Market to Witness Rapid Growth - GlobeNewswire

Added to Collection on: 2025-02-20 18:04:57

Tags for this article:

Antibody-drug conjugates
Antibody-drug conjugate
Seagen
Patritumab deruxtecan
Ifinatamab deruxtecan
Trastuzumab deruxtecan
Daiichi Sankyo
ImmunoGen
Sotio
Deruxtecan
Targeted therapy
HER2
Patritumab
France
Japan
United Kingdom
ADC Therapeutics SA.
Germany
Italy
United States
Ladiratuzumab vedotin
Spain

Click the tags to see associated articles and topics

View Article Details
DESTINY-Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously ...

Added to Collection on: 2025-03-31 16:27:08

Tags for this article:

Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Cancer treatments
Trastuzumab deruxtecan
Antibody-drug conjugate
Pembrolizumab
HER2
Trastuzumab
Daiichi Sankyo
Chemotherapy regimen
Merck & Co. Inc
United States

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data

Added to Collection on: 2025-04-22 12:36:11

Tags for this article:

Antineoplastic drugs
Immunology
Antibody-drug conjugates
Orphan drugs
Daiichi Sankyo
Trastuzumab deruxtecan
Antibody-drug conjugate
Pertuzumab
AstraZeneca
HER2
Trastuzumab
Breast cancer

Click the tags to see associated articles and topics

View Article Details
HER2 Low Cancers Market: Epidemiology, Therapies, Companies, - openPR.com

Added to Collection on: 2025-07-08 11:40:32

Tags for this article:

Antibody-drug conjugates
Immunology
Breast cancer
Orphan drugs
Antineoplastic drugs
Trastuzumab deruxtecan
Antibody-drug conjugate
HER2
Trastuzumab
Daiichi Sankyo
Oncology
AstraZeneca
DelveInsight Business Research LLP

Click the tags to see associated articles and topics

View Article Details
Pfizer's Latest Study on HER2-positive Breast Cancer: Key Insights for Investors

Added to Collection on: 2025-08-14 16:33:25

Tags for this article:

Antineoplastic drugs
Orphan drugs
Antibody-drug conjugates
Cancer treatments
Quinazolines
Tucatinib
Trastuzumab deruxtecan
HER2
Trastuzumab
Breast cancer
Deruxtecan
Trastuzumab emtansine
Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
- GeneOnline News

Added to Collection on: 2025-08-15 17:05:46

Tags for this article:

Antibody-drug conjugates
Immunology
Biotechnology
Specialty drugs
Antineoplastic drugs
Trastuzumab deruxtecan
Trastuzumab
Antibody-drug conjugate
Virus
Deruxtecan
HER2
Immune system

Click the tags to see associated articles and topics

View Article Details
Antibody–bottlebrush prodrugs pack a punch for targeted cancer therapy - Nature

Added to Collection on: 2025-09-09 10:30:03

Tags for this article:

Antibody-drug conjugates
Immunology
Antibody-drug conjugate
Biotechnology
Genetic engineering
Trastuzumab deruxtecan
Deruxtecan
HER2
Trastuzumab

Click the tags to see associated articles and topics

View Article Details
AZN, Daiichi's Enhertu sBLA Gets FDA Priority Review for Breast Cancer - TradingView

Added to Collection on: 2025-09-25 18:19:17

Tags for this article:

Antibody-drug conjugates
Immunology
Antineoplastic drugs
Antibody-drug conjugate
Biotechnology
Genetic engineering
Trastuzumab deruxtecan
AstraZeneca
Daiichi Sankyo
Patritumab deruxtecan
Pertuzumab
Raludotatug deruxtecan
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Book a Demo